ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
Clinical trial NCT01683656 · TERMINATED
Trial details
- NCT number
- NCT01683656
- Sponsor
- Calmy Alexandra
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-07-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.